Long-term ICS use in COPD increases risks of severe health conditions like Type 2 diabetes and fractures. Read more!

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

Nonadherence or inadequate medical management may also play a role in exacerbations. In a subgroup evaluation of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints ...

The following is a summary of “Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean ...

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Given the rising prevalence of cognitive impairment in COPD, researchers have called for increased efforts to identify risk ...

This is followed by an update on the approach to the management of the different types of small lung nodules. This article discusses the diagnostic approach to pulmonary nodules, and the clinical ...

Cardiopulmonary risk has recently been proposed and is defined as: The risk of serious and/or cardiovascular events in ...

Global Market Trends and Projections. The global market for Chronic Obstructive Pulmonary Disease (COPD) and asthma diagnostic and monitoring devices was valued at US$ 7.77 billio ...

Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) diseases that cause breathing difficulty and coughing. Asthma affects about ...

Among patients with COPD or fibrotic ILD, participation in a 3-week inpatient pulmonary rehabilitation program resulted in functional independence improvement, according to results published in ...

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...